Skye Bioscience Inc (SKYE)

[zenvesting]

Matt, this is definitely not my typical low OS, low float kind of stock.

This 2/12 presentation showed their OS @ 144 million, accounting for full conversion of preferred shares....and I am uncertain if that accounts for their recent PP:
https://backend.otcmarkets.com/otcapi/company/sec-filings/12544571/content/html#NEMUS_EX991_HTM

I like their pipeline, I like the management teams experience at major biotech/pharma companies, but the value here is dubious....it looks like a value relative to most other marijuana stocks....but that's about it.

I have a starter position and am watching curiously what exactly their "recapitalization plan" is.....